Viral structure and classification
-
All viruses contain genetic material (DNA or RNA, never both) and a protein capsid.
-
Some viruses have an envelope derived from the host cell membrane.
-
Classification by genetic material: DNA viruses (e.g., Herpesviridae, Adenoviridae) and RNA viruses (e.g., Orthomyxoviridae, Retroviridae).
-
Baltimore Classification groups viruses based on their replication strategy (I–VII).
Viral life cycle
-
Steps: Attachment → Penetration → Uncoating → Replication → Assembly → Release.
-
Lytic cycle leads to cell death; lysogenic cycle may lead to latency or transformation.
-
Key targets for neutralizing antibodies: viral attachment and entry proteins.
Viral replication strategies
-
DNA viruses typically replicate in the nucleus using host DNA-dependent RNA polymerase.
-
RNA viruses replicate in the cytoplasm using viral RNA-dependent RNA polymerase (RdRp).
-
Retroviruses (e.g., HIV) use reverse transcriptase to integrate into host DNA.
-
RdRp lacks proofreading → high mutation rate → rapid evolution and resistance.
Viral pathogenesis and host response
-
Infectivity: ability to infect; Pathogenicity: ability to cause disease; Virulence: severity of disease.
-
Host immune response includes innate (interferons) and adaptive (T cells, antibodies).
-
Viruses evade immunity via intracellular replication, infecting immune cells, and rapid mutation.
-
Cytopathic effects: cell lysis, syncytia formation, inclusion bodies.
Oncogenic viruses
-
Viruses can induce cancer by integrating into host genome and altering cell cycle regulation.
-
Examples:
-
HPV → cervical, anal, oropharyngeal cancers (types 16, 18)
-
-
-
EBV → Burkitt lymphoma, nasopharyngeal carcinoma
-
-
-
HBV/HCV → hepatocellular carcinoma
-
-
-
HTLV-1 → adult T-cell leukemia
-
Antiviral therapy and resistance
-
Targets: viral entry, nucleic acid synthesis, protein processing, release.
-
Examples:
-
Acyclovir → inhibits viral DNA polymerase (HSV, VZV)
-
-
-
Oseltamivir → inhibits neuraminidase (Influenza)
-
-
-
Zidovudine → reverse transcriptase inhibitor (HIV)
-
-
Resistance arises via mutations in viral enzymes (e.g., thymidine kinase, reverse transcriptase).
Diagnostic principles
-
Viruses are obligate intracellular → not visible on light microscopy.
-
Common diagnostics: PCR, antigen detection, serology (IgM/IgG), culture (limited use).
-
Cytopathic effects in cell culture can aid diagnosis (e.g., syncytia in measles).
Learning goals
- Identify the distinctive structures of a virus and describe their use in classification of viruses and their function in the typical viral life cycle
- Describe the factors that enable a virus to cause disease
- Describe the mechanism of oncogenesis for each oncogenic virus
- Explain the factors that contribute to the development of antiviral resistance and provide an example
Study materials
These materials are not required; they are supplementary to large-group session. They are intended as a curated guide to content focused on the learning objectives. There are both textbook and video resources for this session for students to use per their preference. For each reference, I have designated the learning goal addressed with a learning goal icon and and number.
Click the book icons below to go to the library resources listed.
-
Sherris Medical Microbiology, 7e
Focus on chapter introduction/overview box and study the “key points” in blue text/blue boxes on-line.
1 Chapter 6: Viruses—Basic Concepts
Familiarize yourself with terminology and variations in sections on viral components (Viral structure, Genome structure, and Capsid structure).
-
Sherris Medical Microbiology, 7e
2 3 Chapter 7: Pathogenesis of Viral Infection
- 3 Section on Viral transformation: Note types of viruses and mechanisms associated with oncogenic transformation.
- 2 Section on Host Defenses, Adaptive Immune Responses, and Virus-Induced Immunopathology and Immunosuppression: Focus specifically on the section on virulence and cytopathogenicity.
-
Sherris Medical Microbiology, 7e
4 Chapter 8: Antiviral Agents and Resistance
- Sections on General Considerations and Antiviral Resistance: Focus on the discussion of what factors increase likelihood of resistant mutations.
- Section on Key Conclusions: Read key conclusions in light of basic viral structure and function. (specific antiviral agents will be covered later in the course).
Additional resources
-
Classification of Medically Important Viruses
-
RNA Viruses by System
-
Jawetz, Melnic, & Adelberg’s Medical Microbiology, 27e
Chapter 29 General Properties of Viruses.
Figure 29-5: Nice graphic comparing life cycle of DNA vs RNA viruses.
-
Levinson Review of Microbiology and Immunology, 14e
Chapter 31: Classification of Medically Important Viruses.
Figure 31-1 and 31-2.
